Status:
UNKNOWN
Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
the Prognostic Value of Ferritin
Glycosylated Ferritin in SARS-CoV-2 Infection in Hospitalized COVID-19 Patients
Eligibility:
All Genders
18+ years
Brief Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new coronavirus responsible for the pandemic called coronavirus disease 2019 (COVID-19), which appeared in China in December 2019 and ...
Eligibility Criteria
Inclusion
- Patient hospitalized in the internal medicine department of the Croix-Rousse hospital and positive for the SARS-COV 2 (nasopharyngeal sample, the test was appoved by the French national medical authorities).
Exclusion
- Not applicable
Key Trial Info
Start Date :
June 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT04469153
Start Date
June 29 2020
End Date
December 31 2020
Last Update
July 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
hopital de la Croix Rousse
Lyon, Auvergne-Rhône-Alpes, France, 69317